Results 131 to 140 of about 54,939 (306)

Severe fever with thrombocytopenia syndrome in China [PDF]

open access: yesThe Lancet Infectious Diseases, 2018
Meihua Yan, Wenquan Niu
openaire   +2 more sources

European Guideline (EuroGuiDerm) on atopic eczema: Living update

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
The updated guideline includes a new evidence‐based recommendation for the IL‐13 inhibitor lebrikizumab. In addition, the Janus kinase inhibitors baricitinib and abrocitinib, which were initially only approved for adult patients, are now also recommended for children from the age of 2 and adolescents from the age of 12, respectively.
A. Wollenberg   +31 more
wiley   +1 more source

The First Identification and Retrospective Study of Severe Fever With Thrombocytopenia Syndrome in Japan [PDF]

open access: bronze, 2013
Toru Takahashi   +49 more
openalex   +1 more source

A phase 1, first‐in‐human, dose‐escalation study of JNJ‐74856665 (dihydroorotate dehydrogenase inhibitor) alone or in combination in patients with AML or MDS

open access: yes
British Journal of Haematology, EarlyView.
Emma Searle   +30 more
wiley   +1 more source

Comparison of 5‐Fluorouracil/Leucovorin and Capecitabine as Adjuvant Therapies in Biliary Tract Cancer

open access: yesJournal of Gastroenterology and Hepatology, EarlyView.
ABSTRACT Background The prognosis of biliary tract cancer (BTC) is poor, and recurrence rates remain high even after curative resection. This study aimed to compare the efficacy and safety of capecitabine and 5‐fluorouracil/leucovorin (FL) as adjuvant treatments following curative resection in patients with BTC.
Tae Seung Lee   +13 more
wiley   +1 more source

Gaucher disease, state of the art and perspectives

open access: yesJournal of Internal Medicine, EarlyView.
Abstract Knowledge about Gaucher disease (GD), considered a model for rare diseases, has considerably increased since its discovery. The pathophysiology of this lysosomal disorder is better known, and specific therapies that can control many aspects of the disease have been developed, particularly for the most common form, Type 1 GD.
Fabrice Camou, Marc G. Berger
wiley   +1 more source

Structure of Severe Fever with Thrombocytopenia Syndrome Virus Nucleocapsid Protein in Complex with Suramin Reveals Therapeutic Potential [PDF]

open access: bronze, 2013
Lianying Jiao   +16 more
openalex   +1 more source

Plasma exchange and ribavirin for rapidly progressive severe fever with thrombocytopenia syndrome [PDF]

open access: gold, 2013
Won Sup Oh   +5 more
openalex   +1 more source

Architecture of severe fever with thrombocytopenia syndrome virus

open access: yesProtein & Cell, 2023
Zixian Sun   +8 more
openaire   +2 more sources

Severe Fever with Thrombocytopenia Syndrome Virus, South Korea, 2013 [PDF]

open access: diamond, 2014
Sun-Whan Park   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy